Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapansutrile in Acute Myocardial Infarction
NCT05880355Phase 1Not yet recruiting
- Sponsor
- University of Virginia
- Start
- Apr 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dapansutrile in myocardial infarction (MI) (2 arms), sponsored by University of Virginia. Primary endpoint: Remote plaque volume at 6 months. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dapansutrile
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT05880355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05880355.